Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling-Reference-Cited by-同舟云学术

Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling

Published:2011-04-11 Issue:4 Volume:6 Page:e18136
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tian Xia,Vroom Christina,Ghofrani Hossein Ardeschir,Weissmann Norbert,Bieniek Ewa,Grimminger Friedrich,Seeger Werner,Schermuly Ralph Theo,Pullamsetti Soni Savai

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Primary pulmonary hypertension.;LJ Rubin;N Engl J Med,1997

2. Cellular and molecular mechanisms of pulmonary vascular remodeling.;KR Stenmark;Annu Rev Physiol,1997

3. Inhaled iloprost for severe pulmonary hypertension.;H Olschewski;N Engl J Med,2002

4. Sildenafil citrate therapy for pulmonary arterial hypertension.;N Galie;N Engl J Med,2005

5. Bosentan therapy for pulmonary arterial hypertension.;LJ Rubin;N Engl J Med,2002

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 3-trifluoromethyl-substituted pyrazoles as selective phosphodiesterase 10A inhibitors for orally attenuating isoprenaline-induced cardiac hypertrophy;Chinese Chemical Letters;2024-05

2. Phosphodiesterases in heart and vessels- From Physiology to Diseases;Physiological Reviews;2023-11-16

3. Phosphodiesterase type 10A inhibitor attenuates lung fibrosis by targeting myofibroblast activation;iScience;2023-05

4. A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects;Frontiers in Pharmacology;2022-11-09

5. The Biological Relevance of Papaverine in Cancer Cells;Cells;2022-10-26